Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Isolated new onset 'atypical' optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up.
Quantitative MRI Analysis of the Brain after Twenty-Two Years of Neuromyelitis Optica Indicates Focal Tissue Damage.
Leukoencephalopathy due to Oral Methotrexate.
Development of a cell-based assay for the detection of anti-aquaporin 1 antibodies in neuromyelitis optica spectrum disorders.
Structure and inhibition of herpesvirus DNA packaging terminase nuclease domain.
Amyloid PET imaging in multiple sclerosis: an (18)F-florbetaben study.
The risks for falls and fractures in multiple sclerosis.
Personalized medicine in multiple sclerosis: hope or reality?
Therapeutic plasma exchange in neuromyelitis optica: A case series.
Angiopoietin-1 ameliorates inflammation-induced vascular leakage and improves functional impairment in a rat model of acute experimental autoimmune encephalomyelitis.
Regional Heterogeneity of Cuprizone-Induced Demyelination: Topographical Aspects of the Midline of the Corpus Callosum.
Case of Type 1 Diabetes Mellitus Following Interferon β-1a Treatment for Multiple Sclerosis.
Perivenular brain lesions in a primate multiple sclerosis model at 7-tesla magnetic resonance imaging.
[Treatment of relapses of multiple sclerosis (a review)].
A proposed modification to the McDonald 2010 criteria for the diagnosis of primary progressive multiple sclerosis.
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis.
Peripheral elevation of TNF-α leads to early synaptic abnormalities in the mouse somatosensory cortex in experimental autoimmune encephalomyelitis.
Core outcome measures for exercise studies in people with multiple sclerosis: recommendations from a multidisciplinary consensus meeting.
(18)F-fluoroethyl-L-tyrosine positron emission tomography for the differential diagnosis of tumefactive multiple sclerosis versus glioma: A case report.
Application of laser radiation and magnetostimulation in therapy of patients with multiple sclerosis.
Low body weight linked to PML risk with natalizumab in MS
Clostridium perfringens Epsilon Toxin Causes Selective Death of Mature Oligodendrocytes and Central Nervous System Demyelination.
Month of birth, vitamin D and risk of immune mediated disease: a case control study.
[Fingolimod compassionate use program : Case study on the concept of a therapy option for multiple sclerosis prior to marketing approval.]
Helicobacter pylori serology in autoimmune diseases - fact or fiction?
Pages
« first
‹ previous
…
293
294
295
296
297
298
299
300
301
…
next ›
last »